SPECTAbrain: Screening Patients With Brain Tumors for Efficient Clinical Trial Access

Stopped This study has been merged with 1553 SPECTA, in which brain patients are enrolled

Conditions

• Brain Neoplasms

Interventions

• GENETIC: Tumour markers testing

Sponsor

European Organisation for Research and Treatment of Cancer - EORTC